Showing results (31-40 of 163) with videos related to

Sort By:
Pageof 17
Clinical Drug Investigation|May 15, 2016
Osimertinib (AZD9291) and CNS Response in Two Radiotherapy-Naïve Patients with EGFR-Mutant and T790M-Positive Advanced Non-Small Cell Lung CancerBiagio Ricciuti, Rita Chiari, Pietro Chiarini, et al.
Medical Oncology (Northwood, London, England)|April 27, 2017
Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidenceBiagio Ricciuti, Marta Brambilla, Giulio Metro, et al.
Drugs in Context|August 1, 2022
Advanced non-small-cell lung cancer: how to manage non-oncogene diseaseAndrea De Giglio, Alessandro Di Federico, Chiara Deiana, et al.
Medical Oncology (Northwood, London, England)|January 21, 2016
Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapyBiagio Ricciuti, Clelia Mencaroni, Luca Paglialunga, et al.
Lung Cancer Management|January 16, 2019
Targeting EGFR and ALK in NSCLC: current evidence and future perspectiveChiara Bennati, Luca Paglialunga, Biagio Ricciuti, et al.
Cancer Treatment Reviews|April 6, 2015
Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancerRaffaele Califano, Aidalena Abidin, Noor-Ul-Ain Tariq, et al.
Recenti Progressi in Medicina|December 21, 2016
Sacrum colon-rectal cancer metastasis: microwave ablation for palliative pain treatmentDaniele Maiettini, Verena De Angelis, Luigina Graziosi, et al.
Drugs in Context|August 17, 2022
Non-small-cell lung cancer: how to manage <i>EGFR</i>-mutated diseaseFederica Pecci, Luca Cantini, Giulio Metro, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 23, 2003
Successful paternity with microassisted fertilization after total body irradiation-based conditioning for autologous bone marrow transplantationNicola Petti, Gabriel Anghel, Mauro Schimberni, et al.
Therapeutic Advances in Medical Oncology|June 14, 2017
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapyBiagio Ricciuti, Sara Baglivo, Luca Paglialunga, et al.
Pageof 17